ClinicalTrials.gov record

Completed Not applicable Interventional Accepts healthy volunteers Results available

Effect of Omega-3 Supplementation During Pregnancy on Regulation of Stress

ClinicalTrials.gov ID: NCT01158976

Open the official record

This page only displays public information reproduced from the official ClinicalTrials.gov record NCT01158976. It adds no medical advice, opinions, or eligibility judgments. The official record remains the source of truth for eligibility criteria, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Nov 14, 2026, 6:32 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Impact of Omega-3 Intake During Pregnancy on Maternal Stress and Infant Outcome

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This will be the first study of the effect of essential fatty acid supplementation in pregnant women living in inner-city poverty on the stress response system during pregnancy. The investigators proposed that essential fatty acid supplementation will be associated with reductions in the experience of stress, more modulated hormonal response to stress, and more optimal regulation of emotion and attention in the infant, even within the context inner-city poverty.

Study identification

NCT ID: NCT01158976
Recruitment status: Completed
Study type: Interventional
Phase: Not applicable
Lead sponsor: University of Chicago; Other
Enrollment: 64 participants

Conditions and interventions

Conditions

Healthy Pregnant Women

Interventions

Docosahexanoic Acid Dietary Supplement
Placebo Other

Dietary Supplement · Other

Eligibility (public fields only)

Age range: 20 Years to 34 Years
Sex: Female
Healthy volunteers: Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Dec 2009 (Type not available)
Primary completion: Jun 2013 (Actual)
Completion: Jun 2013 (Actual)
Last update posted: May 30, 2018

2009 – 2013

United States locations

U.S. sites: 2
U.S. states: 2
U.S. cities: 2

Facility	City	State	ZIP	Site status
University of Chicago	Chicago	Illinois	60637	—
University of Pittsburgh Medical Center	Pittsburgh	Pennsylvania	15213	—

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT01158976, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted May 30, 2018 · Synced Nov 14, 2026